cefixime
A third-generation cephalosporin antibiotic bearing vinyl and (2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetamido groups at positions 3 and 7, respectively, of the cephem skeleton. It is used in the treatment of gonorrhoea, tonsilitis, pharyngitis, bronchitis, and urinary tract infections.
Machine-generated and unreviewed. Identity, structure and cross-references come straight from ChEBI's and CARD's own data; no curator has signed off on this record yet.
Classification
cephalosporinARO:0000032
- cephalosporin
CHEBI:23066 - cephalosporin
ARO:0000032
Chemical structure
| Molecular formula | C16H15N5O7S2 |
|---|---|
| Charge | 0 |
| Average mass | 453.458 Da |
| Monoisotopic mass | 453.04129 Da |
| Source | ChEBI |
| InChIKey | OKBVVJOGVLARMR-QSWIMTSFSA-N |
[H][C@]12SCC(C=C)=C(C(=O)O)N1C(=O)[C@H]2NC(=O)/C(=N\OCC(=O)O)c1csc(N)n1
InChI=1S/C16H15N5O7S2/c1-2-6-4-29-14-10(13(25)21(14)11(6)15(26)27)19-12(24)9(20-28-3-8(22)23)7-5-30-16(17)18-7/h2,5,10,14H,1,3-4H2,(H2,17,18)(H,19,24)(H,22,23)(H,26,27)/b20-9-/t10-,14-/m1/s1
Also called
- cefixima
- cefiximum
- 7β-{(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetamido}-3-ethenyl-3,4-didehydrocepham-4-carboxylic acid
- (6R,7R)-7-({(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetyl}amino)-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- (−)-cefixim
- CFM
- necopen
Cross-references
- cefixime
ARO:3000646 - beilstein:6025058
- cas:79350-37-1
- kegg.compound:C06881
- chembl:CHEMBL1541
- pubchem.compound:5362065
Drug registries
Patents and articles
Activity roles
- antimicrobial agent
CHEBI:33281 - antibacterial drug
CHEBI:36047
Source concepts
| Source | Native ID | Label | Minted CURIE | Version |
|---|---|---|---|---|
| ARO | ARO:3000646 |
cefixime | antibioticmech:aro-6fbe9bca14 |
2026-08-30 |
| CHEBI | CHEBI:472657 |
cefixime | antibioticmech:chebi-1371a3fd71 |
2026-08-30 |
Molecular targets
beta-lactam sensitive penicillin-binding protein PROTEIN DIRECT_BINDING_TARGET
Activity spectrum
| Organism | Activity | MIC | Disk diffusion | Assay | Strain | Sample/genome | Evidence |
|---|---|---|---|---|---|---|---|
| Neisseria gonorrhoeae NCBITaxon:485 | — | 1.0 mg/L | — | Broth microdilution cefixime MIC; modal MIC reported; interpreted using CLSI 2026 M100 Ed36. | 1280 |
BioSample SAMN35332250 |
EvidencePage data (JSON.gz) |
| Neisseria gonorrhoeae NCBITaxon:485 | — | >1.0 mg/L | — | Broth microdilution cefixime MIC; modal MIC reported; interpreted using CLSI 2026 M100 Ed36. | 1281 |
BioSample SAMN35332251 |
EvidencePage data (JSON.gz) |
Resistance mechanisms
ANTIBIOTIC_INACTIVATION 6
| Determinant | ARO ID | Organism | Gene families | Evidence |
|---|---|---|---|---|
| CMY-2 | ARO:3002013 | — | ||
| CTX-M-27 | ARO:3001889 | — | ||
| CTX-M-3 | ARO:3001866 | — | ||
| PDC-3 | ARO:3002500 | — | ||
| PDC-5 | ARO:3002502 | — | ||
| blaS1 | ARO:3005111 | — |
ANTIBIOTIC_TARGET_ALTERATION 2
| Determinant | ARO ID | Organism | Gene families | Evidence |
|---|---|---|---|---|
| Neisseria gonorrhoeae PBP2 conferring resistance to beta-lactam antibiotics | ARO:3004832 | — | ||
| Neisseria meningititis PBP2 conferring resistance to beta-lactam | ARO:3003937 | — |
Curation history
-
SEEDED_FROM_SOURCES
Seeded from data/raw/ inventories (ARO, CHEBI)
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
CURATED_RESISTANT_TAXA
Added two stable-URL CDC/FDA AR Isolate Bank Panel 10 cefixime-resistant Neisseria gonorrhoeae MIC observations for AR-1280 and AR-1281.
-
STRUCTURED_ACTIVITY_BIOSAMPLE_ACCESSIONS
Structured BioSample accessions on 2 activity_spectrum observation(s) where evidence notes already named exactly one accession.